SunLink Health Systems reports net earnings of $496,000 for the quarter ended September 30, 2009

SunLink Health Systems, Inc. (NYSE Amex: SSY) today announced earnings from continuing operations for its fiscal quarter ended September 30, 2009 of $549,000, or $0.07 per fully diluted share, compared to a loss from continuing operations of $603,000, or $0.08 per fully diluted share, for the quarter ended September 30, 2008. Included in the results for the fiscal quarter ended September 30, 2009 is the pre-tax gain of $2,342,000 from the September 2009 sale of three home health businesses.

SunLink reported net earnings of $496,000, or $0.06 per fully diluted share for the quarter ended September 30, 2009, compared to a net loss of $664,000, or $0.08 per fully diluted share for the comparable quarter a year ago.

Consolidated net revenues from continuing operations for the quarters ended September 30, 2009 increased by 2.5% to $47,825,000 compared to $46,678,000 in the comparable period a year ago. The Specialty Pharmacy Segment net revenues of $10,332,000 in the quarter ended September 30, 2009 increased $721,000, or 7.5% from the prior year. The Healthcare Facilities Segment net revenues of $37,493,000 in the current quarter increased $426,000, or 1.1%, from the prior year and included $337,000 from state indigent care programs and positive prior year third-party payor settlements compared to $678,000 in the quarter ended September 30, 2008.

The company reported operating profit from continuing operations for the quarter ended September 30, 2009 of $2,048,000 compared to an operating profit for the quarter ended September 30, 2008 of $78,000. Included in operating profit in the current year is the pre-tax gain of $2,342,000 on the sale of the home health businesses. Excluding this gain, the operating profit in the current year decreased $372,000, primarily due to increased bad debt expense for the Healthcare Facilities Segment. In the quarter ended September 30, 2009 the provision for bad debts as a percentage of net revenue for the Healthcare Facilities Segment increased to 17.1% from 14.4% last year, or approximately $1,073,000. Adjusted EBITDA at SunLink’s Healthcare Facilities Segment (a non-GAAP measure of the liquidity of a company) in the first fiscal quarter decreased to $1,829,000 from $2,566,000 in the comparable quarter a year ago. Adjusted EBITDA for SunLink’s Specialty Pharmacy Segment increased to $660,000 from $622,000 in the comparable quarter a year ago.

Robert M. Thornton, Jr., SunLink’s CEO, said, “This quarter’s Healthcare Facilities Segment results were negatively impacted by the higher provision for bad debts as well as weak volume. Unemployment has increased in each of our Healthcare Facilities markets over the last year and ranges from 8.2% to 14.0% in our communities. We believe the lost jobs in our communities have contributed to the reduction in patient volume as well as increased bad debts. Equivalent admissions increased 4.9% in this year’s quarter, but not enough to offset the 11.7% decline in inpatient admissions. In our efforts to increase volume across our system we continue to recruit physicians, with a net total of seven recruited this quarter.

The Specialty Pharmacy Segment was a meaningful contributor this quarter and increased its net revenues 7.5% and its EBITDA contribution 6.1% in the quarter.

We invested $872,000 in capital in our facilities this quarter, including equipment upgrades and replacements at six facilities and at Carmichael’s. These investments are designed to improve the attractiveness of our facilities to physicians and patients, and in the case of Carmichael's to enhance the efficiency of their operations.

Our achievements of clinical excellence throughout the SunLink system have not gone unrecognized. Recently the company’s Gilmer Nursing Home was chosen as one of Consumers’ Research of American’s Top Nursing Homes and is included in its annual Guide to Top Nursing Homes’ for the second consecutive year.”

Source: SunLink Health Systems, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Exploring the potential of personalized precision medicine for healthcare industry